Anti-tumor activities of matrine and oxymatrine: Literature review

Tumor Biology

Volumn 35, Issue 6, 2014, Pages 5111-5119

  Liu, Yan ^a,c   Xu, Yang ^b   Ji, Weidan ^b   Li, Xiaoya ^b   Sun, Bin ^b   Gao, Quangen ^a,c   Su, Changqing ^b  

^a First Hospital of Wujiang City   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Anticancer activity; Matrine; Molecular mechanism; Oxymatrine

Indexed keywords

MATRINE; OXYMATRINE;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; AUTOPHAGY; CANCER PREVENTION; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; DRUG MECHANISM; HUMAN; METASTASIS INHIBITION; MULTIDRUG RESISTANCE; NONHUMAN; PLANT ROOT; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SOPHORA; TUMOR INVASION;

ALKALOIDS; ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; CELL CYCLE; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; HUMANS; QUINOLIZINES; TELOMERASE;

EID: 84904719739     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1680-z     Document Type: Review

References (95)

1. Cai XZ, Huang WY, Qiao Y, Du SY, Chen Y, Chen D, et al. Inhibitory effects of curcumin on gastric cancer cells: a proteomic study of molecular targets. Phytomedicine. 2013;20:495-505.
2. Bishayee A, Politis T, Darvesh AS. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma. Cancer Treat Rev. 2010;36:43-53.
3. Liu TY, Tan ZJ, Jiang L, Gu JF, Wu XS, Cao Y, et al. Curcumin induces apoptosis in gallbladder carcinoma cell line GBC-SD cells. Cancer Cell Int. 2013;13(1):64.
4. Wang S, Yu S, Shi W, Ge L, Yu X, Fan J, et al. Curcumin inhibits the migration and invasion of mouse hepatoma Hca-F cells through down-regulating caveolin-1 expression and epidermal growth factor receptor signaling. IUBMB Life. 2011;63(9):775-82.
5. Saleem M, Murtaza I, Tarapore RS, Suh Y, Adhami VM, Johnson JJ, et al. Lupeol inhibits proliferation of human prostate cancer cells by targeting beta-catenin signaling. Carcinogenesis. 2009;30(5):808-17.
6. Saleem M, Maddodi N, Abu Zaid M, Khan N, bin Hafeez B, Asim M, et al. Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis. Clin Cancer Res. 2008;14(7):2119-27. (Pubitemid 351551124)
7. Funaya N, Haginaka J. Matrine- and oxymatrine-imprinted monodisperse polymers prepared by precipitation polymerization and their applications for the selective extraction of matrine-type alkaloids from Sophora flavescens Aiton. J Chromatogr A. 2012;1248:18-23.
8. Lai JP, He XW, Jiang Y, Chen F. Preparative separation and determination of matrine from the Chinese medicinal plant Sophora flavescens Ait by molecularly imprinted solid-phase extraction. Anal Bioanal Chem. 2003;375:264-9. (Pubitemid 41201303)
9. Liu JY, Hu JH, Zhu QG, Li FQ, Wang J, Sun HJ. Effect of matrine on the expression of substance P receptor and inflammatory cytokines production in human skin keratinocytes and fibroblasts. Int Immunopharmacol. 2007;7:816-23. (Pubitemid 46635279)
10. Sun J, Mao J, Liu X, Wang Y, Sun Y, He Z. Separation and mechanism elucidation for six structure-like matrine-type alkaloids by micellar liquid chromatography. J Sep Sci. 2009;32:2043-50.
11. Guzman JR, Koo JS, Goldsmith JR, Muhlbauer M, Narula A, Jobin C. Oxymatrine prevents NF-kappaB nuclear translocation and ameliorates acute intestinal inflammation. Sci Rep. 2013;3:1629.
12. Cao YG, Jing S, Li L, Gao JQ, Shen ZY, Liu Y, et al. Antiarrhythmic effects and ionic mechanisms of oxymatrine from Sophora flavescens. Phytother Res. 2010;24:1844-9.
13. Yang Y, Xiu J, Zhang X, Zhang L, Yan K, Qin C, et al. Antiviral effect of matrine against human enterovirus 71. Molecules. 2012;17:10370-6.
14. Chai NL, Fu Q, Shi H, Cai CH, Wan J, Xu SP, et al. Oxymatrine liposome attenuates hepatic fibrosis via targeting hepatic stellate cells. World J Gastroenterol. 2012;18:4199-206.
15. Li XM, Brown L. Efficacy and mechanisms of action of traditional Chinese medicines for treating asthma and allergy. J Allergy Clin Immunol. 2009;123:297-306. quiz 7-8.
16. Liu H, Sun Y, Gao Y, Chen F, Xu M, Liu Z. The analgesic effect and mechanism of the combination of sodium ferulate and oxymatrine. Neurochem Res. 2010;35:1368-75.
17. Kan QC, Zhu L, Liu N, Zhang GX. Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity. Immunol Res. 2013;56:189-96.
18. Zhang J, Li Y, Chen X, Liu T, Chen Y, He W, et al. Autophagy is involved in anticancer effects of matrine on SGC-7901 human gastric cancer cells. Oncol Rep. 2011;26:115-24.
19. Zhang Y, Zhang H, Yu P, Liu Q, Liu K, Duan H, et al. Effects of matrine against the growth of human lung cancer and hepatoma cells as well as lung cancer cell migration. Cytotechnology. 2009;59:191-200.
20. Li LQ, Li XL, Wang L, Du WJ, Guo R, Liang HH, et al. Matrine inhibits breast cancer growth via miR-21/PTEN/Akt pathway in MCF-7 cells. Cell Physiol Biochem. 2012;30:631-41.
21. Zhang JQ, Li YM, Liu T, He WT, Chen YT, Chen XH, et al. Antitumor effect ofmatrine in human hepatoma G2 cells by inducing apoptosis and autophagy. World J Gastroenterol. 2010;16:4281-90.
22. Chen H, Zhang J, Luo J, Lai F, Wang Z, Tong H, et al. Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the NF-kappaB-mediated VEGF signaling pathway. Oncol Rep. 2013;30:589-95.
23. Jin H, Sun Y, Wang S, Cheng X. Matrine activates PTEN to induce growth inhibition and apoptosis in V600EBRAF harboring melanoma cells. Int J Mol Sci. 2013;14:16040-57.
24. Zhang S, Zhang Y, Zhuang Y, Wang J, Ye J, Zhang S, et al. Matrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and Akt inactivation. PloS One. 2012;7:e46853.
25. Zhang L, Wang T, Wen X, Wei Y, Peng X, Li H, et al. Effect of matrine on HeLa cell adhesion and migration. Eur J Pharmacol. 2007;563:69-76. (Pubitemid 46602230)
26. Yan F, Liu Y, Wang W. Matrine inhibited the growth of rat osteosarcoma UMR-108 cells by inducing apoptosis in a mitochondrial-caspase- dependent pathway. Tumour Biol. 2013;34:2135-40.
27. Ramasamy K, Agarwal R. Multitargeted therapy of cancer by silymarin. Cancer Lett. 2008;269:352-62.
28. Liang CZ, Zhang JK, Shi Z, Liu B, Shen CQ, Tao HM. Matrine induces caspase-dependent apoptosis in human osteosarcoma cells in vitro and in vivo through the upregulation of Bax and Fas/FasL and downregulation of Bcl-2. Cancer Chemother Pharmacol. 2012;69:317-31.
29. Zhao B, Li B, Bai S, Shen L, Ren R, Jonas JB, et al. Effects of matrine on proliferation and apoptosis of cultured retinoblastoma cells. Graefes Arch Clin Exp Ophthalmol. 2012;250:897-905.
30. Xing Y, Yan F, Liu Y, Liu Y, Zhao Y. Matrine inhibits 3 T3-L1 preadipocyte differentiation associated with suppression of ERK1/2 phosphorylation. Biochem Biophys Res Commun. 2010;396:691-5.
31. Yu HB, Zhang HF, Li DY, Zhang X, Xue HZ, Zhao SH. Matrine inhibits matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. J Asian Nat Prod Res. 2011;13:242-50.
32. Wang YP, Zhao W, Xue R, Zhou ZX, Liu F, Han YX, et al. Oxymatrine inhibits hepatitis B infection with an advantage of overcoming drug-resistance. Antiviral Res. 2011;89:227-31.
33. Sun Q, Ma W, Gao Y, Zheng W, Zhang B, Peng Y. Meta-analysis: therapeutic effect of transcatheter arterial chemoembolization combined with compound kushen injection in hepatocellular carcinoma. Afr J Tradit Complement Altern Med. 2012;9:178-88.
34. Luo C, Zhu Y, Jiang T, Lu X, Zhang W, Jing Q, et al. Matrine induced gastric cancer MKN45 cells apoptosis via increasing proapoptotic molecules of Bcl-2 family. Toxicology. 2007;229:245-52. (Pubitemid 44937494)
35. Dai ZJ, Gao J, Ji ZZ, Wang XJ, Ren HT, Liu XX, et al. Matrine induces apoptosis in gastric carcinoma cells via alteration of Fas/FasL and activation of caspase-3. J Ethnopharmacol. 2009;123:91-6.
36. Yu P, Liu Q, Liu K, Yagasaki K, Wu E, Zhang G. Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NFkappaB signaling. Cytotechnology. 2009;59:219-29.
37. Song G, Luo Q, Qin J, Wang L, Shi Y, Sun C. Effects of oxymatrine on proliferation and apoptosis in human hepatoma cells. Colloids Surf B: Biointerfaces. 2006;48:1-5.
38. Zou J, Ran ZH, Xu Q, Xiao SD. Experimental study of the killing effects of oxymatrine on human colon cancer cell line SW1116. Chin J Dig Dis. 2005;6:15-20. (Pubitemid 40467729)
39. Zhang S, Qi J, Sun L, Cheng B, Pan S, Zhou M, et al. Matrine induces programmed cell death and regulates expression of relevant genes based on PCR array analysis in C6 glioma cells. Mol Biol Rep. 2009;36:791-9.
40. Ling Q, Xu X, Wei X, Wang W, Zhou B, Wang B, et al. Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome c. J Exp Clin Cancer Res. 2011;30:66.
41. Liu XS, Jiang JK, Jiao XY, Wu YE, Lin JH. Matrine-induced apoptosis in leukemia U937 cells-involvement of caspases activation and MAPK-independent pathways. Planta Med. 2006;72:501-6.
42. Liu TY, Song Y, Chen H, Pan SH, Sun XY. Matrine inhibits proliferation and induces apoptosis of pancreatic cancer cells in vitro and in vivo. Biol Pharm Bull. 2010;33:1740-5.
43. Ma L, Wen S, Zhan Y, He Y, Liu X, Jiang J. Anticancer effects of the Chinese medicine matrine on murine hepatocellular carcinoma cells. Planta Med. 2008;74:245-51. (Pubitemid 351449946)
44. Wang L, You Y, Wang S, Liu X, Liu B, Wang J, et al. Synthesis, characterization and in vitro anti-tumor activities of matrine derivatives. Bioorg Med Chem Lett. 2012;22(12):4100-2.
45. Shi C, Yu L, Yang F, Yan J, Zeng H. A novel organoselenium compound induces cell cycle arrest and apoptosis in prostate cancer cell lines. Biochem Biophys Res Commun. 2003;309:578-83. (Pubitemid 37083290)
46. Zhao JF, Xie GR, Li XM, Chen WT, Sun ML, Fang Z, et al. Effect of Matrine on cell cycle and human telomerase reverse transcriptase of human salivary adenoid cystic carcinoma. Hua Xi Kou Qiang Yi Xue Za Zhi. 2010;28:234-40.
47. Zhang Z, Wang X, Wu W, Wang J, Wang Y, Wu X, et al. Effects of matrine on proliferation and apoptosis in gallbladder carcinoma cells (GBC-SD). Phytother Res. 2012;26:932-7.
48. Harbour JW, Dean DC. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 2000;14:2393-409.
49. Jiang H, Hou C, Zhang S, Xie H, Zhou W, Jin Q, et al. Matrine upregulates the cell cycle protein E2F-1 and triggers apoptosis via the mitochondrial pathway in K562 cells. Eur J Pharmacol. 2007;559:98-108. (Pubitemid 46295409)
50. Degterev A, Boyce M, Yuan J. A decade of caspases. Oncogene. 2003;22:8543-67. (Pubitemid 38028527)
51. Spencer SL, Sorger PK. Measuring and modeling apoptosis in single cells. Cell. 2011;144:926-39.
52. Zhang Y, Sun S, Chen J, Ren P, Hu Y, Cao Z, et al. Oxymatrine induces mitochondria dependent apoptosis in human osteosarcoma MNNG/HOS cells through inhibition of PI3K/Akt pathway. Tumour Biol. 2013. doi:10.1007/s13277-013-1223- z.
53. Bröker LE, Kruyt FAE, Giaccone G. Cell death independent of caspases: a review. Clin Cancer Res. 2005;11:3155-62. (Pubitemid 40627860)
54. Zheng SY, Li DC, Zhang ZD, Zhao J, Ge JF. Adenovirus-mediated FasL gene transfer into human gastric carcinoma. World J Gastroenterol. 2005;11:3446-50. (Pubitemid 40873252)
55. Tan CH, Qian XQ, Jia RD, Wu M, Liang ZQ. Matrine induction of reactive oxygen species activates p38 leading to caspase-dependent cell apoptosis in non-small cell lung cancer cells. Oncol Rep. 2013;30:2529-35.
56. Song MQ, Zhu JS, Chen JL, Wang L, Da W, Zhu L, et al. Synergistic effect of oxymatrine and angiogenesis inhibitorNM-3 on modulating apoptosis in human gastric cancer cells. World J Gastroenterol. 2007;13:1788-93. (Pubitemid 46706010)
57. Jin Y, Hu J, Wang Q, Li Z, Chen Y. Effects of oxymatrine on the apoptosis of human esophageal carcinoma Eca109 cell line and its mechanism. J Huazhong Univ of Sci Technolog Med Sci. 2008;28:314-6.
58. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci. 2006;78:2081-7.
59. Lee TH, Seng S, Sekine M, Hinton C, Fu Y, Avraham HK, et al. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1. PLoS Med. 2007;4:e186.
60. North S, Moenner M, Bikfalvi A. Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors. Cancer Lett. 2005;218:1-14. (Pubitemid 40082696)
61. Qu F, Cui YR, Xu J. Anttumor effects of matrine on murine hepatocarcinoma cell line H22 and the mechanism. Anti-tumor Pharmacy (China). 2011;1:374-8.
62. Hlobilkova A, Ehrmann J, Knizetova P, Krejci V, Kalita O, Kolar Z. Analysis of VEGF, Flt-1, Flk-1, nestin and MMP-9 in relation to astrocytoma pathogenesis and progression. Neoplasma. 2009;56:284-90.
63. Park JH, Jeong YJ, Park KK, Cho HJ, Chung IK, Min KS, et al. Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-kappaB and AP-1-dependent MMP-9 expression. Mol Cells. 2010;29:209-15.
64. Liu XY, Fang H, Yang ZG, Wang XY, Ruan LM, Fang DR, et al. Matrine inhibits invasiveness and metastasis of human malignant melanoma cell line A375 in vitro. Int J Dermatol. 2008;47:448-56. (Pubitemid 351560308)
65. Levy-Adam F, Ilan N, Vlodavsky I. Tumorigenic and adhesive properties of heparanase. Semin Cancer Biol. 2010;20:153-60.
66. Li H, Tan G, Jiang X, Qiao H, Pan S, Jiang H, et al. Therapeutic effects ofmatrine on primary andmetastatic breast cancer. AmJ Chin Med. 2010;38:1115-30.
67. Kundu M, Thompson CB. Autophagy: basic principles and relevance to disease. Annu Rev Pathol. 2008;3:427-55. (Pubitemid 351488288)
68. Yang ZJ, Chee CE, Huang S, Sinicrope FA. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther. 2011;10:1533-41.
69. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999;402:672-6. (Pubitemid 129516338)
70. Wang Z, Zhang J, Wang Y, Xing R, Yi C, Zhu H, et al. Matrine, a novel autophagy inhibitor, blocks trafficking and the proteolytic activation of lysosomal proteases. Carcinogenesis. 2013;34:128-38.
71. Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ, Reddel RR. Protein composition of catalytically active human telomerase from immortal cells. Science. 2007;315:1850-3. (Pubitemid 46580145)
72. Basu N, Skinner HG, Litzelman K, Vanderboom R, Baichoo E, Boardman LA. Telomeres and telomere dynamics: relevance to cancers of the GI tract. Expert Rev Gastroenterol Hepatol. 2013;7:733- 48.
73. Liu HQ, Liu SL, Wang H, Xie XY, Chen XL, Zhang XM, et al. Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer. Diagn Pathol. 2012;7: 1-8.
74. Zhang LP, Jiang JK, Tam JW, Zhang Y, Liu XS, Xu XR, et al. Effects of Matrine on proliferation and differentiation in K-562 cells. Leuk Res. 2001;25:793-800. (Pubitemid 32734092)
75. Fukuchi Y, Yamato K, Kawamura C, Ikeda Y, Kizaki M. p27KIP1 and GATA-1 are potential downstream molecules in activin Ainduced differentiation and apoptosis pathways in CML cells. Oncol Rep. 2006;16:1099-103.
76. Inoue N, Yahagi N, Yamamoto T, Ishikawa M, Watanabe K, Matsuzaka T, et al. Cyclin-dependent kinase inhibitor, p21WAF1/CIP1, is involved in adipocyte differentiation and hypertrophy, linking to obesity, and insulin resistance. J Biol Chem. 2008;283:21220-9.
77. He S, Liu F, Xie Z, Zu X, Xu W, Jiang Y. P-Glycoprotein/MDR1 regulates Pokemon gene transcription through p53 expression in human breast cancer cells. Int J Mol Sci. 2010;11:3309-51.
78. Colabufo NA, Berardi F, Cantore M, ContinoM, Inglese C, Niso M, et al. Perspectives of P-glycoprotein modulating agents in oncology and neurodegenerative diseases: pharmaceutical, biological, and diagnostic potentials. J Med Chem. 2010;53:1883-97.
79. Chai S, To KK, Lin G. Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines. Chin Med. 2010;5:26.
80. Zhang J, Tang AZ. Reversal effect of matrine on drug resistance of human nasopharyngeal carcinoma cell line. Zhong Yao Cai. 2012;35(12):1989-94.
81. Liu F, Liu SY, He SN, Xie ZH, Zu XY, Jiang YY. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells. Oncol Rep. 2010;23:1469-75.
82. Luo SX, Deng WY, Wang XF, Lu HF, Han LL, Chen BB, et al. Molecular mechanism of indirubin-3?-monoxime and matrine in the reversal of paclitaxel resistance in NCI-H520/TAX25 cell line. Chin Med J (Enql). 2013;126:925-9.
83. Gao HY, Li GY, Lou MM, Li XY, Wei XY, Wang JH. Hepatoprotective effect of matrine salvianolic acid B salt on carbon tetrachloride-induced hepatic fibrosis. J Inflamm (Lond). 2012;9:16.
84. Hu ST, Tang Y, Shen YF, Ao HH, Bai J, Wang YL, et al. Protective effect of oxymatrine on chronic rat heart failure. J Physiol Sci. 2011;61:363-72.
85. Xu W, Lin H, Zhang Y, Chen X, Hua B, Hou W, et al. Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonicalWnt/beta-catenin pathway. J Exp Clin Cancer Res. 2011;30:103.
86. Shao Q. The recent effect of radiotherapy combined with compound kushen injection for esophageal cancer. Radiother Oncol. 2011;99: S372-3.
87. Lao Y. Clinical study on effect of matrine injection to protect the liver function for patients with primary hepatic carcinoma after trans-artery chemo-embolization (TAE). Zhong Yao Cai. 2005;28:637-8.
88. Zhang XL, Xu HR, Chen WL, Chu NN, Li XN, Liu GY, et al. Matrine determination and pharmacokinetics in human plasma using LC/MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877:3253-6.
89. Yue PF, Yuan HL, Li XY, Yang M, Zhu WF. Process optimization, characterization and evaluation in vivo of oxymatrine-phospholipid complex. Int J Pharm. 2010;387:139-46.
90. Ruan J, Liu J, Zhu D, Gong T, Yang F, Hao X, et al. Preparation and evaluation of self-nanoemulsified drug delivery systems (SNEDDSs) of matrine based on drug-phospholipid complex technique. Int J Pharm. 2010;386:282-90.
91. Fan R, Liu R, Ma R, Bi K, Li Q. Determination of oxymatrine and its active metabolite matrine in human plasma after administration of oxymatrine oral solution by highperformance liquid chromatography coupled with mass spectrometry. Fitoterapia. 2013;89:271-7.
92. Wu XL, Hang TJ, Shen JP, Zhang YD. Determination and pharmacokinetic study of oxymatrine and its metabolite matrine in human plasma by liquid chromatography tandem mass spectrometry. J Pharml Biomed Anal. 2006;41(3):918-24.
93. Kennedy DA, Seely D. Clinically based evidence of drug-herb interactions: a systematic review. Expert Opin Drug Saf. 2010;9(1):79-124.
94. Hu MJ, Zeng H, Wu YL, Zhang YP, Zhang S, Qiao MM, et al. Synergistic effects of matrine and 5-fluorouracil on tumor growth of the implanted gastric cancer in nudemice. Chin J Dig Dis. 2005;6(2):68-71. (Pubitemid 40936488)
95. Yang CL, Liu SS, Ma YG, Liu YY, Xue YX, Huang B. The influence of intraoperative pleural perfusion with matrinecisplatin or cisplatin on stromal cell-derived factor-1 in nonsmall cell lung cancer patients with subclinical pleural metastasis. Med Oncol. 2012;29(2):574-81.